quinoxalines has been researched along with in 1130 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Chang, KT; Kim, DK; Kim, YK; Kim, YW; Lee, HJ; Lee, JY; Sheen, YY | 1 |
Kim, DK; Kim, YK; Kim, YW; Sheen, YY | 1 |
Hong, JH; Kim, DK; Kim, IY; Kim, SJ; Kwak, C; Lee, GT; Mueller, TJ; Sheen, YY; Watson, JA | 1 |
Choi, MJ; Han, JY; Hong, SS; Jin, HR; Kim, DK; Kim, IH; Kim, SJ; Kim, WJ; Lee, CR; Lee, SJ; Mamura, M; Park, SH; Piao, S; Ryu, JK; Shin, HY; Suh, JK; Zhang, LW | 1 |
Chevalier, RL; Forbes, MS; Galarreta, CI; Kim, DK; Simpkins, LN; Thornhill, BA | 1 |
Kim, DK; Min, KN; Nam, JS; Park, CY; Park, SY; Sheen, YY; Son, JY | 1 |
Avan, A; Binabaj, MM; Ferns, GA; Hassanian, SM; Khazaei, M; Khoshakhlagh, M; Soleimani, A | 1 |
Aishima, S; Anzai, K; Eguchi, Y; Imajo, K; Itoh, Y; Kage, M; Moriguchi, M; Nakajima, A; Oeda, S; Ogawa, Y; Seko, Y; Takahashi, H; Yoneda, M | 1 |
1 review(s) available for quinoxalines and in 1130
Article | Year |
---|---|
Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Imidazoles; Quinoxalines; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta | 2019 |
7 other study(ies) available for quinoxalines and in 1130
Article | Year |
---|---|
Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug.
Topics: Administration, Oral; Animals; Benzamides; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dogs; Enzyme Inhibitors; Half-Life; Haplorhini; Humans; Imidazoles; Injections, Intravenous; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Models, Biological; Protein Serine-Threonine Kinases; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Tissue Distribution | 2008 |
Identification of human cytochrome P450 enzymes involved in the metabolism of IN-1130, a novel activin receptor-like kinase-5 (ALK5) inhibitor.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Haplorhini; Humans; Imidazoles; In Vitro Techniques; Ketoconazole; Mice; Microsomes, Liver; Mixed Function Oxygenases; Oxygenases; Proadifen; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinoxalines; Rats; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Species Specificity | 2008 |
Effect of IN-1130, a small molecule inhibitor of transforming growth factor-beta type I receptor/activin receptor-like kinase-5, on prostate cancer cells.
Topics: Animals; Drug Screening Assays, Antitumor; Humans; Imidazoles; Male; Mice; Prostatic Neoplasms; Quinoxalines; Tumor Cells, Cultured | 2008 |
IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease.
Topics: Animals; Disease Models, Animal; Fibrosis; Humans; Imidazoles; Male; Penile Induration; Penis; Protein Kinase Inhibitors; Quinoxalines; Rats | 2009 |
Transforming growth factor-β1 receptor inhibition preserves glomerulotubular integrity during ureteral obstruction in adults but worsens injury in neonatal mice.
Topics: Age Factors; Animals; Animals, Newborn; Imidazoles; Kidney Glomerulus; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Quinoxalines; Receptors, Transforming Growth Factor beta; Ureteral Obstruction | 2013 |
An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Nucleus; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Female; Humans; Imidazoles; Lung; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Transplantation; Protein Serine-Threonine Kinases; Protein Transport; Quinoxalines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta; Tumor Burden | 2014 |
Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; Aspartate Aminotransferases; Biopsy; Body Mass Index; Elasticity Imaging Techniques; Female; gamma-Glutamyltransferase; Humans; Imidazoles; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Prospective Studies; Quinoxalines; ROC Curve; Young Adult | 2020 |